Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
GlaxoSmithKline ( (GB:GSK) ) has shared an announcement.
GSK has announced the purchase of 175,000 of its own ordinary shares as part of its ongoing buyback program, executed through BNP Paribas. This transaction is part of a non-discretionary agreement with the broker, and since September 30, 2025, GSK has acquired a total of 7,303,500 shares. The purchased shares will be held as treasury shares, and the company now holds 254,768,344 shares in treasury, with 4,060,655,255 shares in issue. This move is likely to impact the company’s share value and voting rights, with treasury shares accounting for 6.27% of voting rights, potentially affecting shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £14.50 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Outperform.
GlaxoSmithKline’s strong financial performance and positive earnings call sentiment are the most significant factors driving the stock score. The company’s robust growth in specialty medicines and successful R&D efforts contribute positively. Technical analysis supports a bullish outlook, while valuation remains reasonable with an attractive dividend yield. Challenges in the U.S. vaccines market and clinical trial delays are noted but do not significantly detract from the overall positive outlook.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a leading global healthcare company, primarily engaged in the development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products. The company focuses on innovative medicines and vaccines, serving various markets worldwide.
Average Trading Volume: 8,074,501
Technical Sentiment Signal: Buy
Current Market Cap: £71.54B
For detailed information about GSK stock, go to TipRanks’ Stock Analysis page.